Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Conduit Pharmaceuticals Inc (CDT)

Conduit Pharmaceuticals Inc (CDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Conduit Pharmaceuticals Announces Leadership Changes GlobeNewswire - Wed Apr 16, 7:30AM CDT

CDT : 0.6201 (-20.51%)
Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects GlobeNewswire - Fri Apr 11, 7:30AM CDT

CDT : 0.6201 (-20.51%)
Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program GlobeNewswire - Thu Apr 10, 7:30AM CDT

CDT : 0.6201 (-20.51%)
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization GlobeNewswire - Mon Apr 7, 7:30AM CDT

CDT : 0.6201 (-20.51%)
Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases GlobeNewswire - Mon Mar 31, 7:30AM CDT

CDT : 0.6201 (-20.51%)
Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904 GlobeNewswire - Wed Mar 19, 7:30AM CDT

CDT : 0.6201 (-20.51%)
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel GlobeNewswire - Thu Mar 6, 8:35AM CST

CDT : 0.6201 (-20.51%)
Conduit Progresses Phase II of its AI Initiative with Sarborg GlobeNewswire - Thu Feb 20, 7:00AM CST

CDT : 0.6201 (-20.51%)
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model GlobeNewswire - Thu Feb 13, 7:00AM CST

CDT : 0.6201 (-20.51%)
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note GlobeNewswire - Tue Feb 11, 8:00AM CST

CDT : 0.6201 (-20.51%)

Barchart Exclusives

1 ‘Defensive’ Cathie Wood Stock to Buy While It’s at a ‘Great Entry Point’ Barchart - 4 minutes ago
One Wall Street analyst is backing up Cathie Wood’s view that DraftKings is a stock to buy in 2025. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot